Biomira - cancer vaccines.2)a late stage drug or two that could propel sales and stock priceTheratope - Phase III for breast cancer, completion Fall of 0.Complete enrolment in the THERATOPE(R) vaccine Phase II pilot study in colorectal cancer, the BLP25 vaccine Phase IIb study in NSCLC and the Phase II pilot study in prostate cancer. BLP25 vaccine is also being tested in a Phase II pilot study in patients with prostate cancer. The purpose of the trial is to determine whether BLP25 vaccine can affect the serum marker prostate specific antigen (PSA). The study will follow patients to see if PSA levels, usually indicative of growing cancer, can be reduced or stabilized.2002 Corporate Goals 3.) partnerships with top biotech/pharma on attractive termsMerck KgaA4.) financial stabilityEnough cash to get by for a few years5.) management that you respect and trust6.) attractive current valuation$1.50/share (up from $0.54 a few days ago). Market cap $80m.If vaccine is approved, how long will it take to make $80m in profit?PuddinHead
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra